InvestorsHub Logo
Followers 35
Posts 6943
Boards Moderated 0
Alias Born 03/31/2020

Re: MontanaState83 post# 281306

Thursday, 06/18/2020 6:47:30 PM

Thursday, June 18, 2020 6:47:30 PM

Post# of 425914
Singer can easily spike this generics' assertion too (if and only if we get a fair panel).

Generics are referencing a court case where they defeat another drug from Nuvo for lack of written description. Nuvo's patents are vague in terms of API amount: "enough to be effective".

Amarin's patents are specific, quantifying API amounts.

Lawyers please chime in, I'm always the layman, but I'm not aware of efficacy data being a universal or even a standard requirement for drug patents.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News